Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,886,983
-
Share change
-
+17,200
-
Total reported value
-
$98,179,468
-
Price per share
-
$52.03
-
Number of holders
-
82
-
Value change
-
+$1,107,608
-
Number of buys
-
41
-
Number of sells
-
22
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2021
As of 30 Jun 2021,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,886,983 shares.
The largest 10 holders included
UBS Group AG, RETIREMENT CAPITAL STRATEGIES, Thrivent Financial for Lutherans, Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, Wealthcare Advisory Partners LLC, ROYAL BANK OF CANADA, Sharkey, Howes & Javer, and FIRST REPUBLIC INVESTMENT MANAGEMENT, INC..
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.